Upon subgroup analysis, PNPLA3 was found to be an independent risk factor for HCC in patients with NASH or ALD-related cirrhosis (OR 1.67, 95% CI 1.27-2.21). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatohepatitis.